{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:49:48Z","timestamp":1779284988972,"version":"3.51.4"},"reference-count":65,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Oncol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Lymphoproliferative neoplasms (LPNs) such as chronic lymphocytic leukemia and non-Hodgkin lymphomas are clinically heterogeneous and frequently associated with recurrence and poor outcomes. Immune checkpoint markers, including programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1), as well as C-X-C motif chemokine receptor 3 (CXCR3) and inflammation-based indices [systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI)], have shown promise in risk stratification but remain underexplored in Egyptian populations.<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To assess the prognostic value of PD-L1\/PD-1 co-expression with CXCR3, SII, SIRI, and CXCR3 expression on monocyte subsets and lymphocytes in Egyptian patients with LPNs.<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>A case-control study was conducted at Kafr Elsheikh University Hospitals (January 2024 to January 2025), including 90 patients with LPNs (chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma) and 90 matched healthy controls. All participants underwent clinical evaluation, laboratory testing (including complete blood count, C-reactive protein, lactate dehydrogenase, and ferritin), and flow cytometry for PD-L1, PD-1, and CXCR3. Inflammatory indices (SII, SIRI, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and ferritin-to-lymphocyte ratio) were calculated. Clinical outcomes included remission, recurrence, and survival.<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>Patients with LPNs had marked hematological and biochemical alterations, including anemia, thrombocytopenia, and reduced neutrophils, with significantly elevated lactate dehydrogenase, C-reactive protein, ferritin, and systemic inflammatory indices (SII, SIRI). Inflammatory ratios (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio) were lower, whereas the ferritin-to-lymphocyte ratio was higher compared with controls. Immune profiling showed significantly increased PD-L1\/CXCR3 and PD-1\/CXCR3 co-expression and higher CXCR3 expression on T lymphocytes. Post-treatment, PD-L1\/CXCR3, CXCR3\/T lymphocyte expression, SII, and SIRI decreased. Prognostic evaluation revealed that SIRI, PD-L1\/CXCR3, and PD-1\/CXCR3 had high accuracy for identifying stage IV disease, with patients showing low baseline levels achieving superior survival (100% follow-up). Clinically, 21.1% achieved complete remission, 26.7% relapsed, and 15.6% died.<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>PD-L1\/PD-1 co-expression with CXCR3, combined with SII and SIRI, constitutes a practical prognostic panel for staging and outcome prediction in Egyptian patients with LPNs. These biomarkers may guide personalized management and therapeutic monitoring.<\/jats:p>","DOI":"10.5306\/wjco.v17.i1.112801","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:12:42Z","timestamp":1768871562000},"source":"Crossref","is-referenced-by-count":1,"title":["Prognostic significance of PD-L1\/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms"],"prefix":"10.5306","volume":"17","author":[{"given":"Dalia E","family":"Sherief","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahla","family":"Nosair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya Mohammed","family":"Abdelhameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Sadaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira A A","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha","family":"Elgamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"B1","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 2010; 83-87"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.21608\/asmj.2022.270222"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1148\/rg.301095088"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2015.1009042"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345149"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060613"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.731798"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0442"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8628540"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/1110-1067.206435"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/437971"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s43046-021-00097-x"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18502\/ijpho.v14i1.14659"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.94"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3230"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.18056\/seci2015.4"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.051870"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013376"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13876"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2025.04.013"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041809"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20945"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.823079"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12544"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000353127"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.2493"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-051458"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235358"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-9-69"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20182174"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12734"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.03.028"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0146"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.009"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.217"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1159\/000489406"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.655259"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5505\/aot.2023.62582"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9651254"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2006.02.001"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxs098"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1500712112"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2010.158"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1223"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-012017-043208"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-629600"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2174\/1574893616666210707101516"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9306"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0806510"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00514"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.2.627"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-023-03126-4"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.007"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3522-3"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100844"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.010"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107161"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00823-5"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125670"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/life13112106"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4103\/ijmpo.ijmpo_70_18"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13167"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21769"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1177\/03008916231221636"}],"container-title":["World Journal of Clinical Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v17\/i1\/112801.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v17\/i1\/112801.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:12:50Z","timestamp":1768871570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v17\/i1\/112801.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":65,"journal-issue":{"issue":"1"},"alternative-id":["112801"],"URL":"https:\/\/doi.org\/10.5306\/wjco.v17.i1.112801","relation":{},"ISSN":["2218-4333"],"issn-type":[{"value":"2218-4333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,24]]}}}